NuDiscovery
Multi-Modal Disease understanding. Our Agentic system works as the guide to tap into the unknown
ReprogrammingBiology
RedesigningLife
AI Native Platform for innovative medicines.
0
Modalities
0+
Programs
0+
Scientists
0
Year Founded
Premise
Advanced Biology x AI
At Micro CRISPR, we believe the convergence of Advanced Biology and Artificial Intelligence has brought medicine to a defining inflection point; one that is poised to shape a new era in healthcare.
By building an integrated technology platform that can convert biological insight into transformative clinical outcomes; We exists to enable this change.
We envision a future in which medicines are increasingly programmable rather than discovered by chance, scalable rather than constrained by complexity, and accessible to all.
The architecture
Six biology platforms.
One AI native R&D stack
MicroCRISPR is built around a unified biological discovery and development architecture. Our six complementary biology modalities provide the technologies required to create the next generation of medicines. At the center of this architecture is Nuvo Labs, our AI-native intelligence engine, designed to identify high-value targets, engineer therapeutic candidates and optimize the path from discovery to development. Rather than operating six independent technology teams, each platform continuously generates data, insights, and learnings that strengthen the entire system.
Six platforms, One integrated intelligence, and A continuously learning therapeutic development Engine.
Our Biology Platforms
01 / 06
Biology platform
Cell Therapy
Engineered living cells
Next-generation cell therapy built on our proprietary engineering platform with plug-and-play synthetic modules for safety, potency and persistence, plus allogeneic-ready and in-vivo CAR programs.
In the portfolio
- Programs
- 13+
- MOST ADVANCED PROGRAMS
- CD19
- Stage
- Approved [India]
Every platform above draws on the engine below
NUVO Labs - The AI engine
Highlighted layers are the ones serving the selected platform
Foundation
Data
Multi-omic, literature and our own weekly assay results
Ideate
NuDiscovery
Target causality and biomarker signatures
Design
Generative
Platform for designing next-generation de novo therapeutics
Predict
Scoring
Potency, selectivity and developability at once
Make
Retrosynthesis
Route ranking, cost and make-ability before chemistry
What the engine does for Cell Therapy
The engine designs the construct and payload architecture, recommends which genes to modify for enhance persistence and exhaustion behavior, cleaner safety profile, etc
↻And the return path: every experiment this platform runs retrains the engine improving the other five
Nuvo Labs
Computational layer highlights.
Where AI meets Biology.
We combine AI, physics, chemistry, and biological intelligence to move from disease insight to novel molecules to real world validation.
NuMol
Physics Grounded AI explorative method of unlocking unknown chemical spaces
NuLabs
State of Art synthesis and BioLab facilities, Designed for AI native biology and effective feedback loops
Careers
Biologist, Chemists and AI engineers running the same engine.
Biologists, chemists and ML engineers on the same programs building what the biology needs.
Partnership
A Platform, open for collaboration.
Built to discover, design to partner.